Format

Send to

Choose Destination
Neuropharmacology. 2014 Dec;87:91-6. doi: 10.1016/j.neuropharm.2014.04.020. Epub 2014 May 9.

Epidemiology of stimulant misuse and abuse: implications for future epidemiologic and neuropharmacologic research.

Author information

1
Pinney Associates, Inc., 4800 Montgomery Lane, Suite 400, Bethesda, MD 20814, USA. Electronic address: kgerlach@pinneyassociates.com.
2
Injury Prevention Research Center, University of North Carolina, Chapel Hill, NC 27599, USA.
3
Pinney Associates, Inc., 4800 Montgomery Lane, Suite 400, Bethesda, MD 20814, USA.
4
Pinney Associates, Inc., 4800 Montgomery Lane, Suite 400, Bethesda, MD 20814, USA; The Johns Hopkins University, School of Medicine, Baltimore, MD 21229, USA.

Abstract

Stimulants are a diverse array of drugs that range from everyday caffeine to prescription medications and illicitly manufactured street drugs. The surveillance of misuse and abuse of stimulants many times confounds prescription and illicit street drugs such that the data are not specific enough to guide mitigation efforts or assess their impact. This review highlights the surveillance efforts that are conducted in the United States (US) for stimulant misuse and abuse. These surveillance efforts include national level surveys as well as reporting systems such as Poison Centers and emergency departments. This epidemiologic analysis has implications for interpreting the current known neuropharmacology of stimulants and possibly informing future neuropharmacology research that may contribute to a better understanding of potential neuropharmacologic factors influencing differing patterns of use, abuse, and adverse consequences associated with various stimulants. This article is part of the Special Issue entitled 'CNS Stimulants'.

KEYWORDS:

Abuse; Illicit stimulants; Misuse; Stimulant surveillance

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center